ROLE OF NITRIC OXIDE IN NMDA-EVOKED RELEASE OF [3H]-DOPAMINE FROM STRIATAL SLICES

Ingeborg Hanbauer(National Heart Lung and Blood Institute), David A. Wink(National Cancer Institute), Yoichi Osawa(National Heart Lung and Blood Institute), Gerald M. Edelman(Rockefeller University), Joseph A. Gaily(Neurosciences Institute)
Neuroreport
May 1, 1992
Cited by 242

Abstract

Evidence that excitatory amino acids act via N-methyl-D-aspartate (NMDA) receptors to evoke the release of catecholamines from axonal terminals and synaptosomes has been used to argue for the presence of pre-synaptic NMDA receptors. NMDA receptor agonists also generate nitric oxide (NO) which rapidly diffuses through neural tissue. We find that exogenously applied NO evokes [3H]-dopamine release from cultured neurons. This release is not blocked by the NMDA antagonist MK-801 nor by tetrodotoxin. Both NG-nitroarginine which inhibits NO synthesis, and hemoglobin which binds extracellular NO, block NMDA-evoked [3H]-dopamine release from striatal slices. A major role of endogenously-synthesized NO may be to evoke neurotransmitter release in local volumes of neural tissue.


Related Papers

No related papers found

Powered by citation graph analysis